Nomura Asset Management International’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Nomura Asset Management International's CRL Position: Q2 2026 in Review
Nomura Asset Management International opened a new position in Charles River Laboratories (CRL) in Q2 2026: 1,100 shares worth $249K. The stake represents ﹤0.01% of the portfolio and ranks #1304 among its holdings. This is a return to the name: Nomura Asset Management International previously reported a position in CRL as recently as Q4 2025.
Nomura Asset Management International first reported a position in CRL in Q4 2025 and has held it in 2 quarters since. The position peaked at $9.34M in Q4 2025. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Nomura Asset Management International held 1,100 shares of Charles River Laboratories worth $249K as of Q2 2026.
- Charles River Laboratories was a new Nomura Asset Management International position in Q2 2026.
- Charles River Laboratories made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1304 holding.
- Nomura Asset Management International first reported a position in Charles River Laboratories in Q4 2025 and has held it in 2 quarters since.
- Nomura Asset Management International's Charles River Laboratories position peaked at $9.34M in Q4 2025.
- 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.